Latest news
Loading news…
Tercica
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Brisbane, California, United States Founded 2000 501-1000 employees For Profit
Tercica, a biotechnology company, develops and commercializes therapeutics for the treatment of endocrine and metabolic diseases.
Tercica was acquired by Ipsen in 2008 for $373M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
10
Patents
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- TRCA
- Exchange
- NASDAQ
- IPO date
- Mar 17, 2004
- Raised at IPO
- $50M
- Delisted
- Oct 17, 2008
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 13
- Active products
- 12
- Patents granted
- 2
- Trademarks
- 0
- Top patent class
- c07
- IT spend
- $9M
Company Info
- Founded
- 2000
- Employees
- 501-1000
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- News articles
- 5
- HQ
- Brisbane, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Exit date
- Mar 17, 2004
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0
- Trend (90d)
- -2
10
professional contacts at Tercica
Contact execs at Tercica →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Tercica
Loading news…
FAQs about Tercica
People who checked this page also checked these
Browse the full Acquirezy directory.